New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 2, 2020 - Cosmo Pharmaceuticals and Acacia Pharma announced the FDA approval of Byfavo (remimazolam), for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
Download PDF
Return to publications
